| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/19/2004 | CN1498112A Combination therapy for estrogen-dependent disorders |
| 05/19/2004 | CN1498108A Nicotinic receptor agonists for treatment of inflammatory diseases |
| 05/19/2004 | CN1498107A Combination of taxane and cyclin-dependent kinase inhibitor |
| 05/19/2004 | CN1498106A Pharmaceutical forms of epothilones for oral administration |
| 05/19/2004 | CN1498105A Synergistic combinations of vitaminosis A receptor ligands and selected cytotoxic agents for treatment of cancer |
| 05/19/2004 | CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496980A N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1496736A Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors |
| 05/19/2004 | CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150175C Derivatives of 1,3,4-oxadiazolone |
| 05/19/2004 | CN1150172C 1,5 benzodiazepine derviatives |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1150035C Recombination plasmid and application in disease prevention and control |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150020C Chinese medicine for treating hernia |
| 05/19/2004 | CN1150017C Medicine for treating cardiovascular damage caused by systematic lupus erythematosus |
| 05/19/2004 | CN1150016C Medicine for treating fever caused by lupus erythematosus immunological disease |
| 05/19/2004 | CN1150015C Medicine for treating leucocytopenia caused by lupus erythematosus |
| 05/19/2004 | CN1150014C Medicine for treating lupus erythematosus |
| 05/19/2004 | CN1150002C Antitumor compsn. contg. synergistic compsn. of anthracycline derivative with camptothecin derivate |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/19/2004 | CN1149996C Hexahydro-pyrido(4,3-B) indole derivatives as antipsychotic drugs |
| 05/19/2004 | CN1149995C Use of quinazolonone-containing compositions in pharmaceutical |
| 05/19/2004 | CN1149983C Compositions and methos for treatment of anorectal disorders |
| 05/19/2004 | CN1149971C Cosmetic or pharmaceutical compositions consisting of liposomes, its preparation method and use |
| 05/18/2004 | US6737520 For use as substrate for ribonuclease and controlling binding affinity/nuclease resistance |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737439 Active cancer chemopreventative and treating agents in mammals, including humans |
| 05/18/2004 | US6737437 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737435 Indole derivatives and their use as MCP-1 antagonist |
| 05/18/2004 | US6737434 Imidazole derivatives or their salts |
| 05/18/2004 | US6737433 Estrogen dependent antitumor agents |
| 05/18/2004 | US6737429 Pyrrole derivatives |
| 05/18/2004 | US6737427 Administering to the patient suffering with the disease caused by overproduction of mucin such as chronic obstructive pulmonary diseases including asthma, emphysema, and chronic bronchitis a mucin glycoprotein synthesis inhibitor |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737416 Phosphonic acid derivative having inhibitory activity against carboxypeptidase B |
| 05/18/2004 | US6737413 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/18/2004 | US6737407 Treatment of obesity |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737086 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 05/18/2004 | CA2301794C Improved enriched platelet wound healant |
| 05/18/2004 | CA2301742C 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
| 05/18/2004 | CA2297279C New cyano-indole compounds that inhibit serotonin recapture, the process for their preparation and the pharmaceutical compounds that contain them |
| 05/18/2004 | CA2159485C Anti-oxydant alkylaryl polyether alcohol polymers |
| 05/13/2004 | WO2004039869A1 High-molecular weight derivatives of camptothecins |
| 05/13/2004 | WO2004039809A1 Novel quinoxaline derivatives |
| 05/13/2004 | WO2004039806A1 Heterocyclic compounds |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039782A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 05/13/2004 | WO2004039407A1 Apoptosis inducer |
| 05/13/2004 | WO2004039406A1 Medicinal preparation having chemotherapeutic encapsulated therein |
| 05/13/2004 | WO2004039404A1 Therapeutic agent for spinal canal stenosis |
| 05/13/2004 | WO2004039403A1 Remedy for corneal failure |
| 05/13/2004 | WO2004039396A1 Drug containing angiotensin convertase |
| 05/13/2004 | WO2004039395A1 Immunnoevasive agent for preventing graft rejection |
| 05/13/2004 | WO2004039389A1 SELECTIVE HUMAN β3 ADRENALIN RECEPTOR AGONIST AGENT |
| 05/13/2004 | WO2004039388A1 α-GLUCOSIDASE INHIBITOR |
| 05/13/2004 | WO2004039383A1 Remedy for fibromyalgia |
| 05/13/2004 | WO2004039378A1 Preparations comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004014917A3 Antitumoral analogs of lamellarins |
| 05/13/2004 | WO2004013101A3 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 05/13/2004 | WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 05/13/2004 | WO2004002461A3 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 05/13/2004 | WO2003106461A3 Pseudopolymorphic forms of a hiv protease inhibitor |
| 05/13/2004 | WO2003080022A3 Analgesics for nasal administration |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003053921A9 Mutant proteinase inhibitors and uses thereof |
| 05/13/2004 | WO2003045977A3 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | WO2002102804A8 New use of specific cyclolignans |
| 05/13/2004 | WO2002072073A3 Pharmaceutical formulation comprising atorvastatin calcium |
| 05/13/2004 | WO2002038171A9 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/13/2004 | WO2002034272A3 Methods of improving central nervous system functioning |
| 05/13/2004 | US20040093637 Hybrid Bacillus thuringiensis delta-endotoxins with novel broad-spectrum insecticidal activity |
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092744 Process for preparing crystalline form I of cabergoline |
| 05/13/2004 | US20040092717 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 05/13/2004 | US20040092709 Peptide mimics of the cytokine receptor common gamma chain and methods and compositions for making and using the same |